Marketing - Press Releases

Date	Title	Company
15-Dec-2020	Sanofi renews partnership with the WHO to fight Neglected Tropical Diseases and eliminate sleeping sickness before 2030	Sanofi
14-Dec-2020	CHMP recommends approval of Plavix® (clopidogrel) with aspirin in adults for certain types of strokes	Sanofi
14-Dec-2020	BAVENCIO® (avelumab) Receives Positive CHMP Opinion for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma	Merck and Pfizer
14-Dec-2020	TYK2 Identified as a Key Genetic Mechanism of Critical Illness in Covid-19 and as an Important Potential Target for Therapy	SAREUM HOLDINGS PLC
14-Dec-2020	OncoZenge raises MSEK 10 ahead of spin-off and separate listing	Moberg Pharma
14-Dec-2020	HBC and Tenet Partners initiate a long-term collaboration to build a global brand and launch HBC’s own branded consumer health products	Hofseth BioCare ASA
14-Dec-2020	Emapalumab submission in China for primary HLH	Orphan Biovitrum AB
14-Dec-2020	Novo Holdings Creates New Rare Bleeding Disorder Company, Hemab	Novo Holdings
14-Dec-2020	Trixeo Aerosphere approved in the EU for maintenance treatment of COPD	AstraZeneca
14-Dec-2020	Celltrion Healthcare receives EU CHMP positive opinion for biosimilar adalimumab, CT-P17	Celltrion Healthcare
10-Dec-2020	Boehringer Ingelheim to Acquire NBE-Therapeutics for EUR 1.18 Billion, Significantly Enhancing Its Cancer Pipeline Portfolio with Novel Antibody-Drug Conjugates	Boehringer Ingelheim
10-Dec-2020	University spin-out fund makes half a million pound first investments	Northern Accelerator
10-Dec-2020	Almac Group Granted Phase I Award Under the ‘Sustainable Innovation Fund’ to Aid COVID-19 Recovery	Almac Group
10-Dec-2020	RDIF and RCIF participate in meeting of Intergovernmental Russian-Chinese Commission for Investment Cooperation	Russian Direct Investment Fund (RDIF)
10-Dec-2020	Stats show increase in mental health drugs prescribed during pandemic	NHS Business Services Authority’s (NHSBSA)
10-Dec-2020	PureTech Initiates Phase 2a trial of LYT-100 (Deupirfenidone) in Lymphedema	PureTech Health plc
10-Dec-2020	Atox Bio Announces FDA Acceptance to File the NDA for Reltecimod to Treat Suspected Organ Dysfunction or Failure in Patients with Necrotizing Soft Tissue Infection (“Flesh-Eating Disease”)	Atox Bio
10-Dec-2020	Moderna Announces First Participants Dosed in Phase 2/3 Study of COVID-19 Vaccine Candidate in Adolescents	Moderna
10-Dec-2020	CPL UK Healthcare (RIG) win back to back framework awards across the NHS.	CPL UK Healthcare
09-Dec-2020	Merck Launches Scepter™ 3.0 Instrument for Wireless Cell Counting Precision	Merck